====== CCT251545 20μM R07 exp326 ====== ==== Mechanism of Action ==== Inhibits CDK8 and CDK19 mediator-associated kinases * **Class / Subclass 1:** Gene Regulation / Transcription Inhibitor * **Class / Subclass 2:** Signal Transduction / Kinase Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%8-{3-Chloro-5-[4-(1-Methyl-1h-Pyrazol-4-Yl)phenyl]pyridin-4-Yl}-2,8-Diazaspiro[4.5]decan-1-One%% * **Synonyms:** N/A * **CAS #:** 1661839-45-7 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/77050682|77050682]] * **IUPAC:** %%8-[3-chloro-5-[4-(1-methylpyrazol-4-yl)phenyl]pyridin-4-yl]-2,8-diazaspiro[4.5]decan-1-one%% * **INCHI Name:** InChI=1S/C23H24ClN5O/c1-28-15-18(12-27-28)16-2-4-17(5-3-16)19-13-25-14-20(24)21(19)29-10-7-23(8-11-29)6-9-26-22(23)30/h2-5,12-15H,6-11H2,1H3,(H,26,30) * **INCHI Key:** LBFYQISQYCGDDW-UHFFFAOYSA-N * **Molecular Weight:** 421.9 * **Canonical SMILES:** CN1C=C(C=N1)C2=CC=C(C=C2)C3=CN=CC(=C3N4CCC5(CCNC5=O)CC4)Cl * **Isomeric SMILES:** N/A * **Molecular Formula:** C23H24ClN5O {{:chemogenomics:structures:chem-0163.svg?nolink}} * **Supplier Name:** Cayman Chemical * **Catalog #:** 18761 * **Lot #:** N/A * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C23H24ClN5O 422.17421; found 422.1743 * **Platform ID:** CCT251545 * **Min:** -8.9474; **Max:** 38.9173 {{:chemogenomics:dose_response:dr_377.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |N/A | | IC30 |N/A | | IC40 |N/A | | IC50 |N/A | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 07 * **Dose**: 20µM * **Days of incubation**: 8 * **Doublings**: 4.0 * **Numbers of reads**: 22004748 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |7/1|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/CCT251545_20uM_Round-7_exp326.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp326.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:S:SLC5A3|SLC5A3]]|-4.07|<0.01| |[[:human_genes:V:VAC14|VAC14]]|-3.34|<0.01| |[[:human_genes:K:KDSR|KDSR]]|-3.24|<0.01| |[[:human_genes:P:PCYT1A|PCYT1A]]|-3.01|<0.01| |[[:human_genes:C:CHKA|CHKA]]|-3.00|<0.01| |[[:human_genes:A:ALG13|ALG13]]|-2.69|0.02| |[[:human_genes:N:NPRL3|NPRL3]]|-2.66|0.09| |[[:human_genes:A:AGPAT6|AGPAT6]]|-2.62|0.03| |[[:human_genes:A:ARL1|ARL1]]|-2.45|0.06| |[[:human_genes:L:LHPP|LHPP]]|-2.42|0.13| |[[:human_genes:F:FLVCR1|FLVCR1]]|-2.39|0.08| |[[:human_genes:K:KRI1|KRI1]]|-2.30|0.61| |[[:human_genes:S:SWI5|SWI5]]|-2.27|0.18| |[[:human_genes:G:GPR107|GPR107]]|-2.26|0.13| |[[:human_genes:C:CCNB1|CCNB1]]|-2.25|0.18| |[[:human_genes:U:UBN2|UBN2]]|-2.25|0.13| |[[:human_genes:G:GCLC|GCLC]]|-2.24|0.13| |[[:human_genes:C:CEPT1|CEPT1]]|-2.22|0.13| |[[:human_genes:A:AGPAT1|AGPAT1]]|-2.17|0.35| |[[:human_genes:N:NAT10|NAT10]]|-2.16|0.17| |[[:human_genes:M:MRPS25|MRPS25]]|-2.12|0.28| |[[:human_genes:C:COG5|COG5]]|-2.12|0.18| |[[:human_genes:W:WDR20|WDR20]]|-2.09|0.21| |[[:human_genes:A:ATG4D|ATG4D]]|-2.08|0.21| |[[:human_genes:F:FAM129C|FAM129C]]|-2.07|0.21| |[[:human_genes:A:ACSL4|ACSL4]]|-2.04|0.24| |[[:human_genes:T:TIGD5|TIGD5]]|-2.02|0.35| |[[:human_genes:S:SATB2|SATB2]]|-2.02|0.26| |[[:human_genes:M:MS4A13|MS4A13]]|-2.01|0.77| |[[:human_genes:M:MTG2|MTG2]]|-2.01|0.73| |[[:human_genes:T:TRDN|TRDN]]|1.98|0.37| |[[:human_genes:M:MBTPS2|MBTPS2]]|1.98|0.43| |[[:human_genes:H:HIST1H2AI|HIST1H2AI]]|2.04|0.30| |[[:human_genes:T:TMEM71|TMEM71]]|2.06|0.29| |[[:human_genes:P:PRPF19|PRPF19]]|2.06|0.52| |[[:human_genes:S:SEC13|SEC13]]|2.06|0.52| |[[:human_genes:U:USP34|USP34]]|2.06|0.29| |[[:human_genes:A:AMFR|AMFR]]|2.08|0.29| |[[:human_genes:P:PUS3|PUS3]]|2.09|0.37| |[[:human_genes:D:DDX10|DDX10]]|2.12|0.26| |[[:human_genes:K:KDM3B|KDM3B]]|2.13|0.33| |[[:human_genes:P:PCDHGA12|PCDHGA12]]|2.13|0.26| |[[:human_genes:R:RALGAPB|RALGAPB]]|2.14|0.26| |[[:human_genes:P:PLK4|PLK4]]|2.14|0.53| |[[:human_genes:Z:ZNF431|ZNF431]]|2.16|0.41| |[[:human_genes:A:AMBRA1|AMBRA1]]|2.24|0.26| |[[:human_genes:M:MBD2|MBD2]]|2.24|0.26| |[[:human_genes:G:GAPDHS|GAPDHS]]|2.25|0.26| |[[:human_genes:B:BAP1|BAP1]]|2.29|0.32| |[[:human_genes:R:RBCK1|RBCK1]]|2.32|0.26| |[[:human_genes:N:NBPF1|NBPF1]]|2.35|0.26| |[[:human_genes:E:EN1|EN1]]|2.37|0.22| |[[:human_genes:P:POLD2|POLD2]]|2.38|0.46| |[[:human_genes:S:SPI1|SPI1]]|2.41|0.26| |[[:human_genes:M:MMS19|MMS19]]|2.44|0.26| |[[:human_genes:P:POLE2|POLE2]]|2.46|0.43| |[[:human_genes:R:RAB5C|RAB5C]]|2.54|0.10| |[[:human_genes:R:RPL12|RPL12]]|2.56|0.27| |[[:human_genes:L:LDB1|LDB1]]|2.68|0.06| |[[:human_genes:Z:ZEB2|ZEB2]]|3.49|<0.01| ^Screen^Correlation^Plot^ |[[:results:exp149|SB203580 25μM R03 exp149]]|0.096|| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|0.085|| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|0.071|| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|0.066|| |[[:results:exp538|ZLN024 50μM R08 exp538]]|0.066|| |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|0.066|| |[[:results:exp358|FK-506 5μM R07 exp358]]|0.062|| |[[:results:exp379|MSC2530818 10μM R07 exp379]]|0.061|| |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|0.061|| |[[:results:exp433|LJH685 50μM R08 exp433]]|0.059|| |[[:results:exp151|SGC0946 7μM R03 exp151]]|0.057|| |[[:results:exp442|Ibrutinib 10μM R08 exp442]]|0.057|| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|0.054|| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|0.052|| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|0.052|| |[[:results:exp90|WYE-354 6μM R02 exp90]]|0.052|| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|0.101|| |[[:results:exp461|BS-181 20μM R08 exp461]]|0.074|| |[[:results:exp169|BH1 1μM R04 exp169]]|0.058|| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|0.053|| {{:chemogenomics:comparison_plots:exp149_vs_exp326.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp530.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp422.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp344.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp538.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp77.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp358.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp379.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp465.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp433.png?nolink |}} {{:chemogenomics:comparison_plots:exp151_vs_exp326.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp442.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp47.png?nolink |}} {{:chemogenomics:comparison_plots:exp233_vs_exp326.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp510.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp90.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp461.png?nolink |}} {{:chemogenomics:comparison_plots:exp169_vs_exp326.png?nolink |}} {{:chemogenomics:comparison_plots:exp326_vs_exp341.png?nolink |}} ^GO Term^Fold Change^Genes^ |CDP-choline pathway|345.40|PCYT1A,CHKA,CEPT1| |phosphatidylcholine biosynthetic process|115.13|PCYT1A,CHKA,GPAT4,CEPT1| |phosphatidylcholine metabolic process|40.63|PCYT1A,CHKA,GPAT4,CEPT1| |glycerophospholipid biosynthetic process|21.48|VAC14,PCYT1A,CHKA,GPAT4,CEPT1,AGPAT1| |glycerolipid biosynthetic process|19.55|VAC14,PCYT1A,CHKA,GPAT4,CEPT1,AGPAT1| |phospholipid biosynthetic process|17.79|VAC14,PCYT1A,CHKA,GPAT4,CEPT1,AGPAT1| |glycerophospholipid metabolic process|15.13|VAC14,PCYT1A,CHKA,GPAT4,CEPT1,AGPAT1| |glycerolipid metabolic process|12.19|VAC14,PCYT1A,CHKA,GPAT4,CEPT1,AGPAT1| |phospholipid metabolic process|11.98|VAC14,PCYT1A,CHKA,GPAT4,CEPT1,AGPAT1| |organophosphate biosynthetic process|9.32|VAC14,PCYT1A,CHKA,GPAT4,CEPT1,AGPAT1,ACSL4| |lipid biosynthetic process|8.44|VAC14,KDSR,PCYT1A,CHKA,GPAT4,AGPAT1,ACSL4| |cellular lipid metabolic process|7.05|VAC14,KDSR,PCYT1A,CHKA,ALG13,GPAT4,CEPT1,AGPAT1,ACSL4| ^GO Term^Fold Change^Genes^ |CHD-type complex|110.53|MBD2,MTA2,GATAD2B| |NuRD complex|110.53|MBD2,MTA2,GATAD2B| |histone deacetylase complex|27.63|MBD2,KDM3B,MTA2,GATAD2B| |chromatin DNA binding|24.03|BAP1,MBD2,KDM3B,MTA2,GATAD2B| |chromatin binding|7.62|LDB1,SPI1,BAP1,MBD2,ZNF431,KDM3B,MTA2,GATAD2B|